WuXi Biologics (Cayman) Inc.
WXIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8,439,058 | $8,279,182 | $9,153,528 | $9,669,839 |
| Short-Term Investments | $3,157,800 | $2,430,609 | $375,155 | $1,573,598 |
| Receivables | $7,028,198 | $5,786,808 | $6,179,282 | $6,184,425 |
| Inventory | $1,655,042 | $1,521,669 | $1,962,544 | $1,765,751 |
| Other Curr. Assets | $3,223,771 | $5,554,923 | $2,146,232 | $2,004,636 |
| Total Curr. Assets | $24,446,633 | $23,573,191 | $19,816,741 | $21,198,249 |
| Property Plant & Equip (Net) | $30,175,140 | $28,435,374 | $30,775,729 | $29,939,471 |
| Goodwill | $1,529,914 | $1,529,914 | $1,529,914 | $1,529,914 |
| Intangibles | $441,104 | $442,369 | $474,803 | $511,834 |
| Long-Term Investments | $3,006,769 | -$30,784 | $2,808,162 | $2,934,286 |
| Tax Assets | $0 | $444,318 | $0 | $235,783 |
| Other NC Assets | $837,827 | $2,583,053 | $700,370 | $226,189 |
| Total NC Assets | $35,990,754 | $33,404,244 | $36,288,978 | $35,377,477 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $60,437,387 | $56,977,435 | $56,105,719 | $56,575,726 |
| Liabilities | – | – | – | – |
| Payables | $969,433 | $747,147 | $874,530 | $833,266 |
| Short-Term Debt | $2,983,608 | $2,619,006 | $1,085,194 | $731,308 |
| Tax Payable | $0 | $720,343 | $0 | $705,116 |
| Deferred Revenue | $0 | $0 | $0 | $430,477 |
| Other Curr. Liab. | $4,534,304 | $4,534,755 | $4,848,520 | $4,935,853 |
| Total Curr. Liab. | $8,487,345 | $8,621,251 | $6,808,244 | $7,636,020 |
| LT Debt | $2,123,454 | $2,320,843 | $3,482,014 | $3,830,051 |
| Deferred Rev, NC | $0 | $460,466 | $0 | $969,233 |
| Deferred Tax Liab, NC | $0 | $97,306 | $0 | $122,540 |
| Other NC Liab. | $761,517 | $0 | $1,174,646 | $0 |
| Total NC Liab. | $2,884,971 | $2,878,615 | $4,656,660 | $4,921,824 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,374,372 | $2,303,649 | $2,410,313 | $2,413,985 |
| Total Liabilities | $11,372,316 | $11,499,866 | $11,464,904 | $12,557,844 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $1,492,076 |
| Common Stock | $223 | $226 | $228 | $235 |
| Retained Earnings | $20,673,210 | $16,355,938 | $16,476,943 | $13,485,787 |
| AOCI | $1,384,039 | $0 | $1,229,277 | $1,781,784 |
| Other Equity | $22,894,962 | $25,463,045 | $22,948,765 | $23,571,715 |
| Total Equity | $44,952,434 | $41,819,209 | $40,655,213 | $40,331,597 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4,112,637 | $3,658,360 | $3,985,602 | $3,686,285 |
| Total Liab. & Tot. Equity | $60,437,387 | $56,977,435 | $56,105,719 | $56,575,726 |
| Net Debt | -$3,331,996 | -$3,339,333 | -$4,586,320 | -$5,108,480 |